Skip to content

Clinical trials

Hodgkin Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Country / region: Russia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20102
20121
20141
20161
20172
20181
20194
20203
20212
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status7
Recruiting5
Active, not recruiting1
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University7
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia3
National Research Center for Hematology, Russia2
Seagen Inc.2
Takeda2
Burnasyan Federal Medical Biophysical Center1
Cytokinetics1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Merck Sharp & Dohme LLC1
Multinational Center for Quality of Life Research, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease26
Lymphoma, Non-Hodgkin5
Lymphoma4
Recurrence4
Hematologic Diseases2
Lymphoma, Large-Cell, Anaplastic2
Anemia, Aplastic1
Enterocolitis, Neutropenic1
Lymphoma, T-Cell, Cutaneous1
Melanoma1

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.